- Home
- BLUE vs NSPR Comparison
BLUE vs NSPR Comparison
Compare BLUE & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLUE
- NSPR
- Stock Information
- Founded
- BLUE 1992
- NSPR 2005
- Country
- BLUE United States
- NSPR Israel
- Employees
- BLUE N/A
- NSPR N/A
- Industry
- BLUE Biotechnology: Biological Products (No Diagnostic Substances)
- NSPR Medical/Dental Instruments
- Sector
- BLUE Health Care
- NSPR Health Care
- Exchange
- BLUE Nasdaq
- NSPR Nasdaq
- Market Cap
- BLUE 62.1M
- NSPR 63.0M
- IPO Year
- BLUE 2013
- NSPR N/A
- Fundamental
- Price
- BLUE $4.08
- NSPR $3.19
- Analyst Decision
- BLUE Hold
- NSPR Strong Buy
- Analyst Count
- BLUE 9
- NSPR 2
- Target Price
- BLUE $49.14
- NSPR $4.75
- AVG Volume (30 Days)
- BLUE 458.1K
- NSPR 52.2K
- Earning Date
- BLUE 03-25-2025
- NSPR 03-05-2025
- Dividend Yield
- BLUE N/A
- NSPR N/A
- EPS Growth
- BLUE N/A
- NSPR N/A
- EPS
- BLUE N/A
- NSPR N/A
- Revenue
- BLUE $53,120,000.00
- NSPR $6,821,000.00
- Revenue This Year
- BLUE $145.30
- NSPR $13.36
- Revenue Next Year
- BLUE $240.19
- NSPR $49.64
- P/E Ratio
- BLUE N/A
- NSPR N/A
- Revenue Growth
- BLUE 144.50
- NSPR 24.70
- 52 Week Low
- BLUE $4.00
- NSPR $1.81
- 52 Week High
- BLUE $38.40
- NSPR $3.42
- Technical
- Relative Strength Index (RSI)
- BLUE 26.22
- NSPR 63.51
- Support Level
- BLUE $6.61
- NSPR $2.60
- Resistance Level
- BLUE $7.55
- NSPR $3.11
- Average True Range (ATR)
- BLUE 0.64
- NSPR 0.28
- MACD
- BLUE -0.11
- NSPR 0.05
- Stochastic Oscillator
- BLUE 2.24
- NSPR 87.15
About BLUE bluebird bio Inc.
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.